The Association Between Chronic Kidney Disease and Third-Degree Atrioventricular Block: A Danish Nationwide Study

Hannah K Wood-Kurland1, Anne Storgaard Nørskov2, Nicholas Carlson3

  • 1Department of Cardiology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Department of Cardiology, North Zealand Hospital, Hillerød, Denmark; Royal Library, Copenhagen University Library Incl. UH, Copenhagen, Denmark.

PubMed

Insights

Chronic kidney disease (CKD) is linked to a higher risk of third-degree atrioventricular block (3AVB). This association is particularly strong in patients undergoing dialysis, highlighting a critical connection between kidney health and heart rhythm.

Area of Science:

  • Cardiology
  • Nephrology
  • Epidemiology

Background:

  • Chronic kidney disease (CKD) is associated with increased cardiac arrhythmias and sudden cardiac death.
  • The specific relationship between CKD and third-degree atrioventricular block (3AVB) remains under-investigated.

Purpose of the Study:

  • To investigate the association between chronic kidney disease (CKD) and the occurrence of third-degree atrioventricular block (3AVB).

Main Methods:

  • A population-based nested case-control study utilizing Danish administrative registries from 1995-2018.
  • Identified 31,301 patients with 3AVB, matched 1:5 with controls.
  • Employed multivariable Cox and logistic regression to analyze CKD association and pacemaker implantation odds, stratified by dialysis status.

Main Results:

  • A significant association was observed between CKD and 3AVB (HR: 1.83; 95% CI: 1.73-1.93) after adjusting for confounders.
  • The association was markedly stronger in dialysis patients (HR: 7.71; 95% CI: 5.84-10.18) compared to non-dialysis CKD patients (HR: 1.73; 95% CI: 1.64-1.83).
  • Pacemaker implantation odds were lower in dialysis patients (OR: 0.77; 95% CI: 0.60-0.98) but similar for non-dialysis CKD and no CKD.

Conclusions:

  • CKD is an independent risk factor for third-degree atrioventricular block (3AVB).
  • Patients with CKD, especially those on dialysis, face a substantially elevated risk of 3AVB.
  • Findings underscore the importance of cardiac monitoring in CKD patients.
Abstract

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
902
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
898